Cancer Treatment (CTHZ) Short Interest Ratio & Short Volume

Cancer Treatment Short Interest Data

Short Selling Cancer Treatment ?

Sign up to receive the latest short interest report for Cancer Treatment and its competitors with MarketBeat's FREE newsletter.

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
5/28/2021	200 shares	$7.40	-77.8%	N/A	0	$0.04
5/14/2021	900 shares	$135.00	+350.0%	N/A	4.5	$0.15
4/30/2021	200 shares	$26.78	No Change	N/A	0.2	$0.13
4/15/2021	200 shares	$34.98	-95.8%	N/A	0.1	$0.17
3/31/2021	4,800 shares	$384.96	No Change	N/A	0.5	$0.08
3/15/2021	4,800 shares	$384.00	No Change	N/A	0.4	$0.08
2/26/2021	4,800 shares	$432.00	No Change	N/A	6.9	$0.09
2/12/2021	4,800 shares	$480.00	-2.0%	N/A	16	$0.10
1/29/2021	4,900 shares	$931.00	+1,125.0%	N/A	3.8	$0.19
1/15/2021	500 shares	$45.00	No Change	N/A	1.3	$0.09
12/31/2020	400 shares	$15.32	-20.0%	N/A	4	$0.04
12/15/2020	500 shares	$75.00	No Change	N/A	1.3	$0.15
11/30/2020	500 shares	$46.50	+25.0%	N/A	2.5	$0.09
11/15/2020	400 shares	$16.00	No Change	N/A	0	$0.04
10/30/2020	400 shares	$28.00	-20.0%	N/A	4	$0.07
10/15/2020	500 shares	$40.00	No Change	N/A	5	$0.08
9/30/2020	500 shares	$40.00	+25.0%	N/A	5	$0.08
9/15/2020	400 shares	$32.00	No Change	N/A	2	$0.08

What is Cancer Treatment's current short interest?: Short interest is the volume of Cancer Treatment shares that have been sold short but have not yet been covered or closed out. As of May 28th, traders have sold 200 shares of CTHZ short. Learn More on Cancer Treatment's current short interest.
Is Cancer Treatment's short interest increasing or decreasing?: Cancer Treatment saw a decline in short interest in May. As of May 28th, there was short interest totaling 200 shares, a decline of 77.8% from the previous total of 900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Tesla, Inc. ($8.35 billion), AstraZeneca PLC ($7.50 billion), Aon plc ($7.09 billion), Block, Inc. ($6.95 billion), Analog Devices, Inc. ($6.90 billion), Advanced Micro Devices, Inc. ($6.79 billion), Charter Communications, Inc. ($6.18 billion), S&P Global Inc. ($5.54 billion), Sea Limited ($4.96 billion), and Wayfair Inc. ($4.25 billion). View all of the most shorted stocks.

What does it mean to sell short Cancer Treatment stock?: Short selling CTHZ is an investing strategy that aims to generate trading profit from Cancer Treatment as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against Cancer Treatment?: A short squeeze for Cancer Treatment occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CTHZ, which in turn drives the price of the stock up even further.
How often is Cancer Treatment's short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CTHZ, twice per month. The most recent reporting period available is May, 28 2021.

Related Companies:

Short Interest Tools:

This page (OTCMKTS:CTHZ) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners